Glenmark readies growth strategy for next 10 years

December 23, 2016Posted By Admin

Glenmark Pharmaceuticals, during its latest analyst meet, rolled out its ten year strategic roadmap for the company. This stresses innovation, complex generics and the specialty segment. Dermatology has been its core area of competence and it has named the oncology and respiratory segments as additional areas of focus.¬†Glenmark¬†believes about 30 per cent of its overall […]


We are social 24/7 - Get in touch